Vontobel Financial Produ... (F35918) - Trades

Play Episode

5min

Proactive - Interviews for investors

GoviEx Uranium CEO on Muntanga feasibility study milestone and market dynamics

GoviEx Uranium CEO Daniel Major talked with Proactive's Stephen Gunnion about the company’s latest milestone—the completion and filing of the feasibility study for its Muntanga Uranium Project in Zambia. Major explained that the study underscores the project's simplicity, highlighting its open-pit heap leaching operation, low technical risk, and strong economics. GoviEx is targeting production by 2028, with financial preparations already in progress. The company has appointed Endeavor Financial to lead the debt financing process and has begun outreach to potential lenders. Meanwhile, environmental approvals are expected by year-end, paving the way for construction. Discussing uranium market dynamics, Major pointed to a growing supply deficit and increasing demand from utilities. Despite market uncertainties, term contracts remain strong at around $80 per pound. He also noted shifting supply chains, with African uranium playing a more prominent role due to restrictions on Russian and Kazakh supply. "The market needs these projects," Major stated. "GoviEx with Muntanga is one of those projects that can come in and support and fill that gap." Watch the full interview for more insights. Don’t forget to like the video, subscribe to our channel, and turn on notifications for future updates. #GoviExUranium #UraniumMining #MuntangaProject #ZambiaMining #NuclearEnergy #UraniumMarket #MiningStocks #EnergyTransition #UraniumSupply #Investing

Proactive - Interviews for investors

Helix Exploration expands with key acquisition at Rudyard

HeLIX Exploration PLC (AIM:HEX) CEO Bo Sears talked with Proactive's Stephen Gunnion about the company’s latest expansion at its Rudyard Project in Montana. Sears highlighted the acquisition of the Weil #1 well and its surrounding 640-acre section, which effectively doubles Helix's production capacity. The purchase, completed for $300,000, presents significant value compared to the estimated $1.3 million cost of drilling a new well. Sears explained that Rudyard’s helium potential has been known since Texaco’s 1960 drilling, but only recently has its full scale been realised. With ongoing development, Helix is transitioning from an exploration-focused approach to a development drilling program, significantly reducing risks in future wells. The company is also preparing to spud the Linda #1 well in April, pending regulatory approvals. Additionally, Sears confirmed that the Darwin #1 well is ready for production as soon as the necessary plant infrastructure is in place. On the Ingomar project, he noted that while initial gas samples were noncommercial, future drilling in the Flathead formation is planned after environmental restrictions lift in mid-June. Stay tuned to Proactive for more updates from Helix Exploration. If you found this video helpful, give it a like, subscribe to our channel, and turn on notifications for future updates. #Helium #HelixExploration #EnergySector #OilAndGas #Drilling #Investment #NaturalResources #EnergyStocks #Montana #Exploration #Mining #StockMarket

Proactive - Interviews for investors

Tonix Pharmaceuticals secures MCDC grant to advance next-gen Mpox & Smallpox vaccine development

Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to announce that the company has been awarded a grant from the Medical CBRN Defense Consortium to support the continued development of its next-generation vaccine candidate. MCDC is a consortium comprising industrial, academic, and non-profit organizations that assist the U.S. government in advancing medical solutions to protect against chemical, biological, radiological, and nuclear threats. Dr. Lederman explained that the vaccine candidate is being developed as an improved immunization option for mpox and smallpox, with the potential for delivery via innovative alternative methods designed to enhance patient compliance, ease of administration, and overall tolerability. The MCDC grant will support comprehensive market analyses, target market identification, and commercialization planning for both private and government sectors. The investigational vaccine is a minimally replicating live-virus formulation based on a modified orthopoxvirus. It has demonstrated the ability to provide single-dose immune protection against mpox in preclinical studies while offering improved tolerability compared to traditional live-virus vaccines. Previous studies have also shown its effectiveness in protecting animals from lethal intratracheal exposure to a more virulent strain of the mpox virus. Tonix is currently preparing for Phase 1 clinical trials in both the United States and Kenya. Kenya, which is on the outskirts of an MPOX outbreak in Africa, presents an opportunity to test the vaccine in an area with a growing case burden. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #Biotech #MPOXVaccine #Smallpox #TNX801 #VaccineDevelopment #ClinicalTrials #PharmaceuticalNews #MedicalResearch #WHO #GlobalHealth #InfectiousDiseases #Biopharma #ProactiveInvestors

Proactive - Interviews for investors

Eclipse Metals secures uranium partnership

Eclipse Metals Ltd (ASX:EPM) executive chairman Carl Popal talked with Proactive about the company’s earn-in agreement with Boss Energy Ltd to advance exploration at the Liverpool Uranium Project in the Northern Territory’s Alligator Rivers Uranium Field. Popal described the deal as a “game changer” that brings funding, technical expertise, and an experienced uranium producer into the project. The agreement allows Boss Energy to earn up to 80% ownership in stages by funding exploration work, with an initial commitment this year followed by further investment. Discussing the potential of the Devil’s Elbow prospect, Popal highlighted its geological similarities to the high-grade Jabiluka deposit. He emphasisd that the project has strong uranium, palladium, and gold mineralisation, with deep drilling planned to explore its full potential. Beyond uranium, Eclipse Metals is advancing its Greenland rare earths projects, with key metallurgical results expected soon. The company is optimistic that its assets, including a large carbonatite deposit, could be significant in the rare earths sector. Watch the full interview to learn more about Eclipse Metals' uranium and critical minerals strategy. Don’t forget to like the video, subscribe to Proactive’s YouTube channel, and turn on notifications for future updates. #EclipseMetals #ASX #ProactiveInvestors #BossEnergy #Uranium #Mining #Investing #RareEarths #Exploration #UraniumStocks #Greenland #CriticalMinerals #Jabiluka #DevilsElbow #StockMarket #Energy

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Vontobel Financial Products GmbH (F35918)

Latest F35918 Trades
Delayed by 15 mins

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Vontobel Financial Products GmbH (F35918) Trades

Vontobel Financial Products GmbH (F35918)

🔥 Trades (Time & Sales) features

Latest F35918 Trades Delayed by 15 mins

Your Recent History

Go Ad-Free

Latest F35918 Trades
Delayed by 15 mins